Dr. Schooley’s call to action: Elevating phage therapy trials through strategic translational research

The 7th World Conference on Targeting Phage Therapy was organized on June 20-21, 2024 at Corinthia Palace Malta. Robert T. Schooley, M.D., Professor of Medicine at the University of California, San Diego, and Co-Director of the Center for Innovative Phage Applications and Therapeutics and member of the Executive Committee for the University of California Disaster…
Posted on March 13, 2024
Read More
The Concluding Remarks of Targeting Phage Therapy 2023 & Future Perspectives

The Concluding Remarks of Targeting Phage Therapy 2023 & Future Perspectives

The 6th World Congress on Targeting Phage Therapy 2023 that was held on June 1-2 in Paris, and gathered more than 150 attendees from 30+ different countries. Targeting Phage Therapy 2023 included more than 71 presentations between major talks, short orals, and posters. The Chairman of the scientific committee Dr. Marvin Edeas Université de Paris,…
Posted on June 9, 2023
Read More
Phage Therapy 2023 Best Short Oral: Bacteriophage-Antibiotic Combination to Allow Liver Transplantation

Phage Therapy 2023 Best Short Oral: Bacteriophage-Antibiotic Combination to Allow Liver Transplantation

The Targeting Phage Therapy 2023 Best Short Oral Presentation award was discerned to: Bacteriophage-Antibiotic Combination Therapy Against Extensively Drug-Resistant Pseudomonas Aeruginosa Infection to Allow Liver Transplantation in a Toddler Brieuc Van Nieuwenhuyse, UC Louvain, Belgium Dr. Van Nieuwenhuyse explained to Targeting Phage Therapy: “My research focuses on bidirectional translational research, trying to analyze specific mechanisms…
Posted on June 5, 2023
Read More
Targeting Phage Therapy 2023 Best Poster: Thermostable Bactericidal Endolysin Discovery

Targeting Phage Therapy 2023 Best Poster: Thermostable Bactericidal Endolysin Discovery

The Targeting Phage Therapy 2023 Best Poster Presentation award was discerned to: New Ways to Fight Bacterial Pathogens: Metagenomics Analysis for the Discovery of a Thermostable Endolysin With High Bactericidal Activity Panagiota Pantiora, Agricultural University of Athens, Greece Ms. Pantiora is currently a PhD student in Enzyme Biotechnology, at the Laboratory of Enzyme Technology of AUA,…
Posted on June 5, 2023
Read More
Phiogen CEO was awarded the Phage Therapy 2023 Best Innovation for their technology platform

Phiogen CEO was awarded the Phage Therapy 2023 Best Innovation for their technology platform

The Targeting Phage Therapy 2023 Best Scientific Contribution award was discerned to: Amanda (Curtis) Burkardt, CEO of PHIOGEN, USA Ms. Burkardt was awarded for creating patient ready products in a remedy ready world. Spun-off from of one of the US’s only phage therapy cores, TAILOR Labs at Baylor College of Medicine, an ambitious new biotech…
Posted on June 3, 2023
Read More
Martha Clokie Editor in Chief of PHAGE Journal was awarded the Phage Therapy 2023 Best Scientific Contribution

Martha Clokie Editor in Chief of PHAGE Journal was awarded the Phage Therapy 2023 Best Scientific Contribution

The Targeting Phage Therapy 2023 Best Scientific Contribution award was discerned to: Martha Clokie, Professor at University of Leicester and Editor in Chief of the PHAGE Journal Prof. Clokie was awarded for her talk on phage therapy challenges and opportunities. In her talk, she elaborated on her team’s work in an agricultural setting that has…
Posted on June 3, 2023
Read More
PHAGE Therapy, Applications, and Research Journal is a contributing partner

PHAGE Therapy, Applications, and Research Journal is a contributing partner

PHAGE Therapy, Applications, and Research Journal is a contributing partner of Targeting Phage Therapy 2023 Conference.  Editor in Chief Prof. Martha Clokie from the University of Leicester will be presenting an introductory talk on  the “Challenges and Opportunities for Bacteriophage Therapy”. All the conference proceedings will be published in the journal. So make sure to…
Posted on May 12, 2023
Read More
BiomX shared their latest data at Targeting Phage Therapy 2023

BiomX shared their latest data at Targeting Phage Therapy 2023

Iddo Nadav Weiner, VP of Research at BiomX, Israel presented a short oral talk entitled “A Phase 1b/2a Randomized, Double-blind, Placebo-controlled Study Evaluating Nebulized Phage Therapy in Cystic Fibrosis Subjects With Chronic Pseudomonas Aeruginosa Pulmonary Infection ” during Targeting Phage Therapy 2023 on June 1-2 in Paris. Dr. Weiner will describe the development of a…
Posted on May 11, 2023
Read More
Phage Therapy 2023 Gathered 70+ Communications, 150+ Attendees, 25+ Industrials

Phage Therapy 2023 Gathered 70+ Communications, 150+ Attendees, 25+ Industrials

More than 125 international participants from 31 different countries will be joined Targeting Phage Therapy 2023 on June 1-2 in Paris. During Targeting Phage Therapy 2023, 70+ communications were presented in the form of major talks, short orals, and posters. Targeting Phage Therapy 2023 created a network of academics and  25+ industrials who presented their…
Posted on April 28, 2023
Read More